Artwork
iconShare
 
Manage episode 471818833 series 2941835
Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week:

The good — Axplora expands its antibody-drug conjugate (ADC) manufacturing capacity to support growing demand.

The bad — Merck KGaA’s CDMO business reports a decline

The ugly — The FDA issues a warning letter to Granules India over manufacturing violations

  continue reading

100 episodes